ARCHIVES

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

This article is from The Cancer Letter archive.

Vol. 27 No. 31 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

Manville Sues U.S. Over “Withheld” Wartime Data

July 22, 1983

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012

In Brief: Maryland Wins Center Planning Grant; CRC Receives $5 Million To Endow Chair

December 10, 1999

In Brief: Esparza, Young, Busch, Rush Head Oncology Societies; Hipple Centers Honors Harry Eagle

June 2, 1989

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006